Next report date
Report period
H2 2023
EPS estimate
—
Revenue estimate
—
−0.065HKD
129.26 MHKD
72.58 MHKD
945.51 M
About EXTRAWELL PHARMACEUTICAL HLDGS
Sector
CEO
Yi Xie
Headquarters
Hong Kong
Website
Employees (FY)
181
Founded
1998
ISIN
BMG3285Q1134
FIGI
BBG000BSKPT6
Extrawell Pharmaceutical Holdings Ltd. is an investment company, which engages in the marketing and distribution of pharmaceutical products. It operates through the following segments: Manufacturing, Trading, and Gene Development. The Manufacturing segment includes the development, manufacture, and sale of pharmaceutical products. The Trading segment covers the marketing and distribution of imported pharmaceutical products. The Gene Development segment focuses on the commercial exploitation and development of genome-related technology. The company was founded on December 8, 1998 and is headquartered in Hong Kong.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 858 is 0.026 HKD — it has decreased by 3.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange EXTRAWELL PHARMACEUTICAL HLDGS stocks are traded under the ticker 858.
EXTRAWELL PHARMACEUTICAL HLDGS is going to release the next earnings report on Jun 28, 2024. Keep track of upcoming events with our Earnings Calendar.
858 stock is 3.85% volatile and has beta coefficient of 0.59. Check out the list of the most volatile stocks — is EXTRAWELL PHARMACEUTICAL HLDGS there?
Yes, you can track EXTRAWELL PHARMACEUTICAL HLDGS financials in yearly and quarterly reports right on TradingView.
858 stock has fallen by 7.14% compared to the previous week, the month change is a 13.33% fall, over the last year EXTRAWELL PHARMACEUTICAL HLDGS has showed a 58.06% decrease.
858 net income for the last quarter is −237.73 M HKD, while the quarter before that showed 83.44 M HKD of net income which accounts for −384.89% change. Track more EXTRAWELL PHARMACEUTICAL HLDGS financial stats to get the full picture.
No, 858 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 858 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXTRAWELL PHARMACEUTICAL HLDGS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 181.00 employees. See our rating of the largest employees — is EXTRAWELL PHARMACEUTICAL HLDGS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXTRAWELL PHARMACEUTICAL HLDGS technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXTRAWELL PHARMACEUTICAL HLDGS stock shows the strong sell signal. See more of EXTRAWELL PHARMACEUTICAL HLDGS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXTRAWELL PHARMACEUTICAL HLDGS EBITDA is 2.51 M HKD, and current EBITDA margin is −3.43%. See more stats in EXTRAWELL PHARMACEUTICAL HLDGS financial statements.